These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35262024)

  • 1. Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test.
    Sluimer J; Goderski G; van den Brink S; Broeders M; Rahamat-Langendoen J; Then E; Wijsman L; Wolters F; van de Bovenkamp J; Melchers WJ; Meijer A
    J Clin Virol Plus; 2021 Dec; 1(4):100042. PubMed ID: 35262024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens.
    Leung EC; Chow VC; Lee MK; Tang KP; Li DK; Lai RW
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33436456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the analytical and clinical performance of two RT-PCR based point-of-care tests; Cepheid Xpert® Xpress CoV-2/Flu/RSV plus and SD BioSensor STANDARD™ M10 Flu/RSV/SARS-CoV-2.
    Jensen CB; Schneider UV; Madsen TV; Nielsen XC; Ma CMG; Severinsen JK; Hoegh AM; Botnen AB; Trebbien R; Lisby JG
    J Clin Virol; 2024 Jun; 172():105674. PubMed ID: 38643722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Evaluation of the Xpert
    Noble LD; Scott LE; Munir R; Du Plessis M; Steegen K; Hans L; Marokane P; Da Silva P; Stevens WS
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.
    Wolters F; Grünberg M; Huber M; Kessler HH; Prüller F; Saleh L; Fébreau C; Rahamat-Langendoen J; Thibault V; Melchers WJG
    J Med Virol; 2021 Oct; 93(10):5798-5804. PubMed ID: 34050951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test.
    Johnson G; Zubrzycki A; Henry M; Ranadheera C; Corbett C; Meyers AFA; Sandstrom PA; Becker MG
    J Clin Virol Plus; 2021 Jun; 1(1):100014. PubMed ID: 35262002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the GeneXpert
    Johnson G; Gregorchuk BSJ; Zubrzycki A; Kolsun K; Meyers AFA; Sandstrom PA; Becker MG
    Can J Microbiol; 2023 Mar; 69(3):146-150. PubMed ID: 36657122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2.
    Köse B; Schaumburg F
    Microbiol Spectr; 2024 Aug; 12(8):e0115324. PubMed ID: 38990032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of a Standard M10 Assay with Xpert Xpress for the Rapid Molecular Diagnosis of SARS-CoV-2, Influenza A/B Virus, and Respiratory Syncytial Virus.
    Abdullah A; Sam IC; Ong YJ; Theo CH; Pukhari MH; Chan YF
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Xpert Xpress CoV-2/Flu/RSV Plus Kit: A Glance at RSV Infection in Adults and Coinfection Rate.
    Alkharsah KR
    Saudi J Med Med Sci; 2024; 12(2):182-187. PubMed ID: 38764565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    Cohen DM; Kline J; May LS; Harnett GE; Gibson J; Liang SY; Rafique Z; Rodriguez CA; McGann KM; Gaydos CA; Mayne D; Phillips D; Cohen J
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses.
    Davies S; Boller E; Chase J; Beaubrun A; Miller C; Jensen I
    J Med Econ; 2024; 27(1):430-441. PubMed ID: 38328858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.
    Zhen W; Manji R; Smith E; Wuitschick J; Lucic D; Berry GJ
    Microbiol Spectr; 2022 Feb; 10(1):e0109021. PubMed ID: 35107357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses.
    Chen JH; Lam HY; Yip CC; Cheng VC; Chan JF; Leung TH; Sridhar S; Chan KH; Tang BS; Yuen KY
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):177-180. PubMed ID: 29262988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the limits of multiplex respiratory virus assays for SARS-CoV-2 at high cycle threshold values: Comparative performance of cobas 6800/8800 SARS-CoV-2 & Influenza A/B, Xpert Xpress SARS-CoV-2/Flu/RSV, and cobas Liat SARS-CoV-2 & Influenza A/B.
    Matic N; Lawson T; Ritchie G; Lowe CF; Romney MG
    J Assoc Med Microbiol Infect Dis Can; 2024 Jan; 8(4):328-335. PubMed ID: 38250621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative practicability and analytical performances of Credo VitaPCR™ Flu A&B and Cepheid Xpert® Xpress Flu/RSV platforms.
    Mboumba Bouassa RS; Tonen-Wolyec S; Rodary J; Bélec L
    Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115381. PubMed ID: 33852989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.